Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the american society for bone and mineral Research

The Association of Race, Gender, and Comorbidity With Mortality and Function After Hip Fracture

(2011) J. D. Penrod et al.   JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES

Healing of non-displaced fractures produced by fatigue loading of the mouse ulna

(2010) Mario D. Martinez et al.   BONE

Atypical fractures of the femur and bisphosphonate therapy

(2010) Andrea Giusti et al.   BONE

Efficacy of continued alendronate for fractures in women with and without prevalent vertebral fracture: The FLEX Trial

(2010) Ann V Schwartz et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Lack of Sustained Response to Teriparatide in a Patient with Adult Hypophosphatasia

(2010) Claudia Gagnon et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Femoral Cortical Stress Lesions in Long-Term Bisphosphonate Therapy: A Herald of Impending Fracture?

(2010) Joyce S B Koh et al.   JOURNAL OF ORTHOPAEDIC TRAUMA

Teriparatide May Accelerate Healing in Delayed Unions of Type III Odontoid Fractures

(2010) Paul T. Rubery et al.   JOURNAL OF SPINAL DISORDERS & TECHNIQUES

Evolving Data about Subtrochanteric Fractures and Bisphosphonates

(2010) Elizabeth Shane   NEW ENGLAND JOURNAL OF MEDICINE

Bisphosphonates and Fractures of the Subtrochanteric or Diaphyseal Femur

(2010) Dennis M. Black et al.   NEW ENGLAND JOURNAL OF MEDICINE

Atypical Femoral Fractures and Bisphosphonate Use

(2010) Christian M. Girgis et al.   NEW ENGLAND JOURNAL OF MEDICINE

Low-Energy Femoral Fractures Associated With Long-Term Bisphosphonate Use in a Rehabilitation Setting: A Case Series

(2010) Robert D. Bunning et al.   PM&R

Incidence of stress fractures of the femoral shaft in women treated with bisphosphonate

(2009) Jörg Schilcher et al.   Acta Orthopaedica

Spontaneous femoral shaft fracture after long-term alendronate

(2009) T. Ali et al.   AGE AND AGEING

Subtrochanteric stress fractures in six patients on long term bisphosphonate therapy: A case series

(2009) D.A. Glennon   BONE

Temporal pattern of gene expression and histology of stress fracture healing

(2009) L.J. Kidd et al.   BONE

Bone Turnover in Bone Biopsies of Patients with Low-Energy Cortical Fractures Receiving Bisphosphonates: A Case Series

(2009) Reina Armamento-Villareal et al.   CALCIFIED TISSUE INTERNATIONAL

Unusual mid-shaft fractures during long-term bisphosphonate therapy

(2009) Clarita V. Odvina et al.   CLINICAL ENDOCRINOLOGY

Case Reports: Subtrochanteric Femoral Stress Fractures after Prolonged Alendronate Therapy

(2009) Katerina Cermak et al.   CLINICAL ORTHOPAEDICS AND RELATED RESEARCH

Case Reports: Two Femoral Insufficiency Fractures after Long-term Alendronate Therapy

(2009) Arkan S. Sayed-Noor et al.   CLINICAL ORTHOPAEDICS AND RELATED RESEARCH

Low-Energy Femoral Fractures Associated with the Long-Term Use of Bisphosphonates

(2009) Kuntheavy Ing-Lorenzini et al.   DRUG SAFETY

National data of 6409 Swedish inpatients with femoral shaft fractures: Stable incidence between 1998 and 2004

(2009) Rüdiger J. Weiss et al.   INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED

Quality of life after a subtrochanteric fracture

(2009) Wilhelmina Ekström et al.   INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED

Bilateral atypical femoral diaphyseal fractures in a patient treated with alendronate sodium

(2009) Joon Kiong LEE   International Journal of Rheumatic Diseases

Bilateral Low-Energy Simultaneous or Sequential Femoral Fractures in Patients on Long-Term Alendronate Therapy

(2009) Craig M. Capeci et al.   JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME

Bilateral Fractures of the Femur Diaphysis in a Patient With Rheumatoid Arthritis on Long-Term Treatment With Alendronate: Clues to the Mechanism of Increased Bone Fragility

(2009) Matthijs P Somford et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Mineralization density distribution of postmenopausal osteoporotic bone is restored to normal after long-term alendronate treatment: qBEI and sSAXS data from the fracture intervention trial long-term extension (FLEX)

(2009) P Roschger et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Teriparatide for acceleration of fracture repair in humans: A prospective, randomized, double-blind study of 102 postmenopausal women with distal radial fractures

(2009) Per Aspenberg et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Prevention of Bone Loss by Zoledronic Acid in Premenopausal Women Undergoing Adjuvant Chemotherapy Persist up to One Year following Discontinuing Treatment

(2009) Dawn L. Hershman et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Recurrent Low-Energy Femoral Shaft Fractures and Osteonecrosis of the Jaw in a Case of Multiple Myeloma Treated With Bisphosphonates

(2009) Jonathan M. Grasko et al.   JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY

Effects of 1 to 3 years' treatment with alendronate on mechanical properties of the femoral shaft in a canine model: Implications for subtrochanteric femoral fracture risk

(2009) David B. Burr et al.   JOURNAL OF ORTHOPAEDIC RESEARCH

Giant Osteoclast Formation and Long-Term Oral Bisphosphonate Therapy

(2009) Robert S. Weinstein et al.   NEW ENGLAND JOURNAL OF MEDICINE

Atraumatic Bilateral Femur Fracture in Long-Term Bisphosphonate Use

(2009) Maria S. Goddard et al.   ORTHOPEDICS

Bisphosphonate-associated femoral fracture: implications for management in patients with malignancies

(2009) N. Napoli et al.   OSTEOPOROSIS INTERNATIONAL

Successful treatment of sternal fracture nonunion with teriparatide

(2009) S. Chintamaneni et al.   OSTEOPOROSIS INTERNATIONAL

Alendronate-related femoral diaphysis fracture—what should be done to predict and prevent subsequent fracture of the contralateral side?

(2009) M. H. Edwards et al.   OSTEOPOROSIS INTERNATIONAL

Excess mortality following hip fracture: a systematic epidemiological review

(2009) B. Abrahamsen et al.   OSTEOPOROSIS INTERNATIONAL

Fragility fractures of the hip and femur: incidence and patient characteristics

(2009) J. W. Nieves et al.   OSTEOPOROSIS INTERNATIONAL

Collagen cross-links as a determinant of bone quality: a possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitus

(2009) M. Saito et al.   OSTEOPOROSIS INTERNATIONAL

Subtrochanteric displaced insufficiency fracture after long‐term alendronate therapy—a case report

(2008) Arkan S Sayed-Noor et al.   Acta Orthopaedica

Stress fracture healing: Fatigue loading of the rat ulna induces upregulation in expression of osteogenic and angiogenic genes that mimic the intramembranous portion of fracture repair

(2008) Gregory R. Wohl et al.   BONE

Alendronate Reduces Bone Toughness of Ribs without Significantly Increasing Microdamage Accumulation in Dogs Following 3 Years of Daily Treatment

(2008) Matthew R. Allen et al.   CALCIFIED TISSUE INTERNATIONAL

Modulation of Dickkopf-1 Attenuates Glucocorticoid Induction of Osteoblast Apoptosis, Adipocytic Differentiation, and Bone Mass Loss

(2008) Feng-Sheng Wang et al.   ENDOCRINOLOGY

An emerging pattern of subtrochanteric stress fractures: A long-term complication of alendronate therapy?

(2008) Ernest Beng Kee Kwek et al.   INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED

Gender differences in epidemiology and outcome after hip fracture

(2008) G. Holt et al.   JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME

Connexin 43 Is Required for the Anti-Apoptotic Effect of Bisphosphonates on Osteocytes and Osteoblasts In Vivo

(2008) Lilian I Plotkin et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Effect of Temporal Changes in Bone Turnover on the Bone Mineralization Density Distribution: A Computer Simulation Study

(2008) Davide Ruffoni et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Atypical Femoral Fractures, Bisphosphonates, and Adult Hypophosphatasia

(2008) Michael P Whyte   JOURNAL OF BONE AND MINERAL RESEARCH

Subtrochanteric and Diaphyseal Femur Fractures in Patients Treated With Alendronate: A Register-Based National Cohort Study

(2008) Bo Abrahamsen et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Severely Suppressed Bone Turnover and Atypical Skeletal Fragility

(2008) Maja Visekruna et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Low-Energy Femoral Shaft Fractures Associated With Alendronate Use

(2008) Andrew S Neviaser et al.   JOURNAL OF ORTHOPAEDIC TRAUMA

Atypical Fractures of the Femoral Diaphysis in Postmenopausal Women Taking Alendronate

(2008) Brett A. Lenart et al.   NEW ENGLAND JOURNAL OF MEDICINE

Collagen maturity, glycation induced-pentosidine, and mineralization are increased following 3-year treatment with incadronate in dogs

(2008) M. Saito et al.   OSTEOPOROSIS INTERNATIONAL

Changes in non-enzymatic glycation and its association with altered mechanical properties following 1-year treatment with risedronate or alendronate

(2008) S. Y. Tang et al.   OSTEOPOROSIS INTERNATIONAL

Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study

(2008) B. A. Lenart et al.   OSTEOPOROSIS INTERNATIONAL

Spectroscopic markers of bone quality in alendronate-treated postmenopausal women

(2008) A. L. Boskey et al.   OSTEOPOROSIS INTERNATIONAL

Prevention of corticosteroid-induced osteonecrosis in rabbits by intra-bone marrow injection of autologous bone marrow cells

(2008) T. Asada et al.   RHEUMATOLOGY

Bone mineralization density distribution in health and disease

(2007) P. Roschger et al.   BONE

Effects of Alendronate on Bone Quality and Remodeling in Glucocorticoid-Induced Osteoporosis: A Histomorphometric Analysis of Transiliac Biopsies

(2006) Pascale M. Chavassieux et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Suppressed Bone Turnover by Bisphosphonates Increases Microdamage Accumulation and Reduces Some Biomechanical Properties in Dog Rib

(2006) Tasuku Mashiba et al.   JOURNAL OF BONE AND MINERAL RESEARCH